• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSL2000162 奥妥珠单抗注射液 obinutuzumab Injection Biological Products(2.2) Import Drug Application 2020-09-27 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2020-09-25 view
JYSB2000165 奥妥珠单抗注射液 obinutuzumab Injection Biological Products Supplementary Application 2020-05-11 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2020-05-10 view
JXSS1900059 奥妥珠单抗注射液 obinutuzumab Injection Biological Products Import Drug Application 2019-09-28 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2019-09-27 view
JXSL2101044 奥妥珠单抗注射液 obinutuzumab Injection Biological Products(2.2) Import Drug Application 2021-06-22 view
JXSB2200102 奥妥珠单抗注射液 obinutuzumab Injection Biological Products(2.2) Supplementary Application 2022-08-24 view
JYSB2101079 奥妥珠单抗注射液 obinutuzumab Injection Biological Products Supplementary Application 2021-07-08 view
JXSB2101063 奥妥珠单抗注射液 obinutuzumab Injection Biological Products(2.2) Supplementary Application 2021-09-26 view
JYSB2200008 奥妥珠单抗注射液 obinutuzumab Injection Biological Products Supplementary Application 2022-01-18 view
JXSB2200064 奥妥珠单抗注射液 obinutuzumab Injection Biological Products(2.2) Supplementary Application 2022-06-03 view
JYSB2400034 奥妥珠单抗注射液 obinutuzumab Injection Biological Products Supplementary Application 2024-02-19 view
JXSL2101130 奥妥珠单抗注射液 obinutuzumab Injection Biological Products(2.2) Import Drug Application 2021-11-16 view
JYSB2400022 奥妥珠单抗注射液 obinutuzumab Injection Biological Products Supplementary Application 2024-02-01 view
JXSL2200165 奥妥珠单抗注射液 obinutuzumab Injection Biological Products(2.2) Import Drug Application 2022-09-15 view
JXSB2300101 奥妥珠单抗注射液 obinutuzumab Injection Biological Products(2.2) Supplementary Application 2023-08-16 view